CGEN - Compugen Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
7,800
17,800
0
712
9,277
Cost of Revenue
684
1,034
0
223
1,633
Gross Profit
7,116
16,766
0
489
7,644
Operating Expenses
Research Development
26,428
30,318
28,583
24,549
21,245
Selling General and Administrative
9,217
9,675
8,822
8,523
7,317
Total Operating Expenses
35,645
39,993
37,405
33,072
28,562
Operating Income or Loss
-28,529
-23,227
-37,405
-32,583
-20,918
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-12
8
-169
392
390
Income Before Tax
-27,617
-22,599
-37,066
-31,486
-19,773
Income Tax Expense
-722
0
0
20
390
Income from Continuing Operations
-26,895
-22,599
-37,066
-31,506
-20,163
Net Income
-26,895
-22,599
-37,066
-31,506
-20,163
Net Income available to common shareholders
-26,895
-22,599
-37,066
-31,506
-20,163
Reported EPS
Basic
-
-0.41
-0.72
-0.62
-0.40
Diluted
-
-0.41
-0.72
-0.62
-0.40
Weighted average shares outstanding
Basic
-
55,277
51,180
50,856
50,437
Diluted
-
55,277
51,180
50,856
50,437
EBITDA
-
-23,227
-37,405
-32,583
-20,918